On Friday, October 23, President Trump issued a Proclamation (the Proclamation) modifying the scope of products from Canada subject to Section 338 tariffs. Please see our previous post on Section 338 tariffs here.
On October 14, 2026, the Bureau of Industry and Security (BIS) issued guidance regarding calculation of “U.S. content” for purposes of the application of Section 232 metal tariffs to mobile industrial equipment and machinery qualifying for preference under the US-Mexico-Canada Agreement (USMCA).
On September 29, 2026, Evonik Corporation and Huntsman International LLC (Petitioners) filed petitions requesting the imposition of antidumping and countervailing duties on imports of certain amine compounds (CACs) from the People’s Republic of China.
On September 24, 2026, the American Alliance of Wooden Fence Producers, comprised of Alta Forest Products, Mendocino Forst Products, and Sierra Pacific Industries, (Petitioner) filed companion petitions requesting the imposition of antidumping and countervailing duties on imports of certain wooden fence pickets from the People’s Republic of China (China).
U.S. Customs and Border Protection (CBP) recently issued guidance via the Cargo Systems Messaging Service (CSMS) on filing entries for imports from Canada subject to duties under Section 338 of the Tariff Act of 1930 (Section 338). We previously covered President Trump’s imposition and subsequent modification of these Section 338 tariffs here, here, and here.
On September 1, we posted on the Government Enforcement, Compliance & Investigations Report about how a Taiwan-based LED manufacturer and its U.S. subsidiary agreed to pay $5.15 million to resolve False Claims Act allegations that they evaded Section 301 tariffs by transshipping Chinese-origin LEDs through Taiwan. The settlement, announced August 5, 2026 by the U.S. Attorney’s
U.S. Customs and Border Protection (“CBP”) issued a Federal Register notice that it is now ready to execute “executing enhanced enforcement procedures.” CBP has indicated that it will start verifying importer of record information provided by each importer on CBP Form 5106, and importers of record have until September 18, 2026, to correct any errors
The Trump Administration has officially reduced tariffs on patented pharmaceuticals and associated pharmaceutical ingredients imported from the United Kingdom (UK) from 10% to 0%. This change, effective July 31, 2026, is the result of an agreement between the United States and the UK, which created a carve out for UK origin pharmaceutical products from the recent national security tariffs imposed on patented pharmaceuticals pursuant to Section 232 of the Trade Expansion Act of 1962 (Section 232).
On August 4, 2026 the Bureau of Industry and Security (BIS) published a notice seeking public comments on expanding tariffs applicable to certain steel, aluminum and copper derivative products under Section 232 of the Trade Expansion Act of 1962 (Section 232) to fourteen (14) additional derivative products.
The list of products proposed to be subject
On August 3, 2026, the state attorney generals of twenty-five states (25) co-led by State of Oregon, Arizona and California filed a complaint in the Court of International Trade (CIT) challenging tariffs imposed under Section 301 of the Trade Act of 1974 (Section 301) to address forced labor. The complaint alleges that Section 301 forced labor tariffs are ultra vires, arbitrary, capricious and contrary to law.
This complaint by the 25 state attorney generals challenging the legality of the Section 301 forced labor tariffs, joins other lawsuits pending before the CIT that were filed by small business plaintiffs, Burlap and Barrel, Inc. and Collective Horology LLC.